Currently, there are 98.25M common shares owned by the public and among those 93.37M shares have been available to trade.
The company’s stock has a 5-day price change of -9.36% and -75.13% over the past three months. SRPT shares are trading -84.63% year to date (YTD), with the 12-month market performance down to -84.39% lower. It has a 12-month low price of $18.30 and touched a high of $168.30 over the same period. SRPT has an average intraday trading volume of 4.86 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -42.61%, -55.47%, and -80.03% respectively.
Institutional ownership of Sarepta Therapeutics Inc (NASDAQ: SRPT) shares accounts for 90.15% of the company’s 98.25M shares outstanding.
It has a market capitalization of $1.87B and a beta (3y monthly) value of 0.57. The earnings-per-share (ttm) stands at -$2.58. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.81% over the week and 12.65% over the month.
Analysts forecast that Sarepta Therapeutics Inc (SRPT) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to decrease by -272.66%, and 172.92% over the next financial year.
TD Cowen coverage for the Sarepta Therapeutics Inc (SRPT) stock in a research note released on June 18, 2025 offered a Hold rating with a price target of $24. Wolfe Research was of a view on June 17, 2025 that the stock is Peer Perform, while Piper Sandler gave the stock Neutral rating on June 16, 2025, issuing a price target of $36. Morgan Stanley on their part issued Equal-Weight rating on June 16, 2025.
